NEWS
25/03/2021
Following the examination of our DSMB committee, Plas-Free proudly announces the completion of the open label phase evaluating CLearPlasma in Upper gastrointestinal bleeding performed in Gemelli Roma, Italy, led by Prof. Francesco Franceschi.
Plas-Free would like to thank the DSMB members and the Chairman, Dr. Cohen Omri for their professional evaluation of the clinical study.
04/02/2021
Plas-Free has successfully completed the open label clinical phase in five upper Gastrointestinal bleeding patients using ClearPlasma in leading hospitals in Israel.
ClearPlasma demonstrated safety and initial efficiency indicated by the reduction of blood loss and more.
10/04/2020
23/12/2019
PlasFree is happy to announce initiating its first clinical study examining its Medical Device CLearPlasma in Upper Gastrointestinal bleeding patients (https://clinicaltrials.gov/ct2/show/NCT04174989?term=clearplasma&draw=2&rank=1).
09/10/2019
PlasFree has received funding from the European Union’s Horizon 2020 research and innovation program SME Instrument Phase 1 grant. EU project 882231 - ClearPlasma.
03/05/2019
PlasFree has successfully passed Stage 2 assessment confirming its management system by BSI (notified body).
28/03/2019
PlasFree has received Seal of Excellence from the European Commission
Read more
03/01/2019
PlasFree has successfully pass Stage1 assessment confirm the management system is and ready to proceed to Stage 2 for the CE mark assessment done by BSI ( notified body)
10/06/2018
Plasfree is now an ISO 13485 certified medical device company
15/04/2018